SGLT2 inhibitors: Safer Teens, Stronger Kidneys, Steadier Glucose

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

🚨 New trial alert! In youth with type 1 diabetes, adding #SGLT2i 💊 (dapagliflozin) to insulin: ✅ Reduced glomerular hyperfiltration ✅ Lowered HbA1c 📉 ✅ Boosted time-in-range ⏱️ 😌 Safe with DKA precautions in place 📄 #ATTEMPTTrial | @NatureMedicine 🔗 https://doi.org/10.1038/s41591-025-03723-6

Episode metadata supplied by the publisher feed · Published Jun 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

SGLT2 inhibitors: Safer Teens, Stronger Kidneys, Steadier Glucose

0:00 3:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 3 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on June 9, 2025.

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!